This study looks at eyes receiving fluocinolone acetonide implants (Retisert) over a 7 year period and concludes that there is a high risk of developing cataracts and increasing intraocular pressure (glaucoma). The study authors include people who were involved in the Bausch and Lomb trials.
This type of implant is not currently licensed for use in the UK, so you would have to be an extremely special circumstance to qualify for this type of treatment at the moment.
However for those with Birdshot, with bad inflammation, who can not tolerate sytemic steroids they do provide a potential, if not ideal option for treating inflammation in the eye.
You can also see our earlier post about this type of device: –https://birdshot.org.uk/dexamethasone-for-ocular-inflammation/